Human and mouse brain-derived endothelial cells require high levels of growth factors medium for their isolation, in vitro maintenance and survival

Navone, Stefania Elena; Marfia, Giovanni; Nava, Sara; Invernici, Gloria; Cristini, Silvia; Balbi, Sergio; Sangiorgi, Simone; Ciusani, Emilio; Bosutti, Alessandra; Alessandri, Giulio; Slevin, Mark; Parati, Eugenio Agostino
June 2013
Vascular Cell;2013, Vol. 5 Issue 1, p1
Academic Journal
Background: Brain microvascular endothelial cells (BMVECs) constitute the primary limitation for passage of ions and molecules from the blood into the brain through the blood brain barrier. Numerous multi-step procedures for isolating and culturing BMVECs have been described. However, each one demonstrates major limitations in purity of culture and/or low proliferation rate. Our goal was to study the efficiency of our pending patent medium, Endothelial Proliferation Medium (EndoPM), on the isolation and purification of human and murine BMVECs. Methods: BMVECs, cultured in EndoPM were compared to those cultured in a commercial medium EBM. Cultures were characterized by flow cytometric analysis, lineage differentiation, the ability to form tube-like structure, immunofluorescence, molecular analyses and also in an in vivo model assay. Moreover permeability was assayed by monitoring the passage of Dextran-FITC through a tight monolayer of BMVECs grown to confluence in Boyden chambers. One way Anova two-tailed test was utilized for all statistical analyses. Results: The properties of ECs in human and murine BMVECs is confirmed by the expression of endothelial markers (CD31, CD105, CD146, Tie-2 and vWF), of representative proangiogenic genes (ICAM1, VCAM1 and integrin ITGAV), of considerable tube-forming ability, with low-density lipoprotein uptake, eNOS and GLUT-1 expression. Furthermore cells are able to express markers of the junctional architecture as VE-cadherin, β-catenin and Claudin-5 and greatly reduce dextran permeability as barrier functional test. Moreover BMVECs spontaneously organize in vascular-like structures and maintain the expression of endothelial markers in an in vivo xenograft model assay. The significant effect of EndoPM is confirmed by the study of proliferation index, survival index and the behaviour of BMVECs and fibroblasts in co-culture conditions. Conclusion: Herein we describe a simple and reproducible method for the isolation and expansion of human and mouse BMVECs, based on a newly formulated medium (EndoPM) with optimized concentration of growth factors (EGF, FGF-2 and Bovine Brain Extract-BBE). This procedure should facilitate the isolation and expansion of human and mouse BMVECs with extended lifetime, good viability and purity. This approach may provide an effective strategy to aid phenotypical and functional studies of brain vessels under physiological and pathological conditions.


Related Articles

  • Antiangiogenics and Metastatic Colorectal Cancer: Who is an Optimal Candidate? Mikhail, Sameh; Tanios, Bekaii-Saab // Cancer & Chemotherapy Reviews;Apr-Jun2014, Vol. 9 Issue 2, p35 

    Angiogenesis is a tightly regulated process that is mediated by a group of angiogenic factors such as vascular endothelial growth factor and its receptors. Given the widespread use of antiangiogenic agents, there has been considerable interest in developing methods to identify subgroups of...

  • A method to tune the shape of protein-encapsulated polymeric microspheres. Alteriis, Renato de; Vecchione, Raffaele; Attanasio, Chiara; Gregorio, Maria De; Porzio, Massimiliano; Battista, Edmondo; Netti, Paolo A. // Scientific Reports;7/31/2015, p12634 

    Protein encapsulation technologies of polymeric microspheres currently in use have been optimized to effectively protect their 'protein cargo' from inactivation occurring in biological environments, preserving its bioactivity during release up to several weeks. The scenario of protein delivery...

  • Optimal outcomes & reduced injection burden with treat & extend. Emery, Faye // Ophthalmology Times Europe;Jul/Aug2015, Vol. 11 Issue 6, p28 

    The article provides the author's view and experience in treating and extending follow-up regimen for wet age-related macular degeneration (AMD). He discusses the introduction of anti-vascular endothelial growth factor (VEGF drugs), such as bevacizumab, ranibizumab, and aflibercept. Information...

  • Intravitreal bevacizumab injection in unrecognised early pregnancy. Sullivan, L; Kelly, S P; Glenn, A; Williams, C P R; McKibbin, M // Eye;Apr2014, Vol. 28 Issue 4, p492 

    PurposeThe use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age.Patients and methodsWe present our experiences following intravitreal injection of bevacizumab during the first...

  • Endostar inhibits ascites formation and prolongs survival in mouse models of malignant ascites. HONGMEI WEI; SHUKUI QIN; XIAOJIN YIN; YALI CHEN; HAIQING HUA; LIN WANG; NINGRONG YANG; YINGXIA CHEN; XIUFENG LIU // Oncology Letters;2015, Vol. 9 Issue 6, p2694 

    Endostar, a modified recombinant human endostatin, inhibits the growth of a variety of tumors by suppressing neovascularization. Vascular endothelial growth factor (VEGF) has an important role in malignant ascites formation. In order to determine whether Endostar can suppress the formation of...

  • Role of vascular endothelial growth factor in the response to vessel injury. Victoria Alvarez Arroyo, M.; Caramelo, Carlos; Angeles Castilla, M.; González Pacheco, Francisco R.; Martín, Olga; Arias, Javier // Kidney International;Dec1998 Supplement 68, Vol. 54, pS7 

    Role of vascular endothelial growth factor in the response to vessel injury. In the post-embryonic life, physiological angiogenesis is tightly controlled. Angiogenesis also occurs in pathological circumstances such as tumor vessel proliferation, retinal neovascularization and ischemia. The...

  • Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. Gumus, Koray; Karakucuk, Sarper; Mirza, G. Ertugrul; Akgun, Hulya; Arda, Hatice; Oner, Ayse O. // British Journal of Ophthalmology;Jun2014, Vol. 98 Issue 6, p796 

    Background To investigate the expression levels of vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 1 (VEGFR-1) and VEGFR-2 in pterygium and to clarify the prognostic significance of these expressions in pterygia. Methods A total of 40 surgically excised...

  • The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review). WEIHUA CHEN; KAILI MAO; ZHONGMIN LIU; ANH TUAN DINH-XUAN // Oncology Letters;2014, Vol. 8 Issue 5, p1907 

    Prostate cancer (PCa) remains a major cause of mortality among males in western countries, with little change in mortality rates observed over the past 25 years. Despite recent advances in therapy, treatment options for metastatic castration-resistant disease remain limited. In terms of...

  • Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia. Wu, Chuanhong; Chen, Jianxin; Chen, Chang; Wang, Wei; Wen, Limei; Gao, Kuo; Chen, Xiuping; Xiong, Sihuai; Zhao, Huihui; Li, Shaojing // Scientific Reports;11/6/2015, p16151 

    Microenvironmental regulation has become a promising strategy for complex disease treatment. The neurovascular unit (NVU), as the key structural basis to maintain an optimal brain microenvironment, has emerged as a new paradigm to understand the pathology of stroke. In this study, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics